Table: Zeria Pharm -2018/19 group results

Zeria Pharmaceutical

10/05/2019 08:00

May 10 (Reuters)- 
          Zeria Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           61.83           64.57          65.00        31.00    
               (-4.2 pct)      (-0.4 pct)     (+5.1 pct)    (+1.7 pct) 
  Operating        3.74            4.83           5.00         1.80    
               (-22.6 pct)     (+6.4 pct)     (+33.8 pct)  (-13.0 pct) 
  Recurring        3.30            5.09           5.00         1.80    
               (-35.2 pct)     (+14.7 pct)    (+51.7 pct)   (-6.0 pct) 
  Net
  Net              3.45            4.16           3.80         1.40    
               (-16.9 pct)     (+17.3 pct)    (+10.0 pct)  (-38.6 pct) 
  EPS           69.56 yen       80.72 yen      79.30 yen    29.22 yen  
  Ann Div       34.00 yen       34.00 yen      34.00 yen               
  -Q2 Div       17.00 yen       17.00 yen      17.00 yen               
  -Q4 Div       17.00 yen       17.00 yen      17.00 yen               
  
  NOTE - Zeria Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T